RapidAI
RapidAI is a trusted leader in deep clinical AI, helping hospitals deliver faster, more informed care through intelligent imaging and integrated workflows. The Rapid Enterprise™ Platform supports disease states across the care spectrum, driving meaningful impact by improving decision-making, patient outcomes, and health-system performance. Used by more than 2,500 hospitals in over 100 countries, RapidAI is the most clinically validated AI platform in healthcare.
Headquarters
San Mateo, California, United States
Company Size
51-200 employees
Founded
2012
RapidAI provides an enterprise clinical AI platform that delivers deep-learning tools to enhance clinical assessment and transform care across health system service lines. Its products analyze clinical and imaging data to accelerate and improve triage, diagnosis, and treatment decisions while enabling program-level monitoring and analytics. The platform is built for scalable, enterprise deployment and integration into provider workflows so hospitals and health systems can standardize AI-driven care pathways and measure outcomes.
RapidAI and Health Holdings Company Partner to Bring Deep Clinical AI to Saudi Arabia
Nov 11, 2025
RapidAI earns US FDA clearance for AI-driven aortic measurement and surveillance product
Nov 18, 2025
RapidAI gains US FDA clearances for five new imaging modules
Nov 26, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for RapidAI.
RapidAI didn’t post a salary, so this is our estimate from similar listings.
RapidAI Lumina 3D: The Best Inventions of 2025
Oct 9, 2025